114 related articles for article (PubMed ID: 20673499)
1. [Expression and its clinical significance of SHP2 in non-small cell lung cancer].
Tang C; Zhou X; Yang H; Wang Q; Zhang R
Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):98-101. PubMed ID: 20673499
[TBL] [Abstract][Full Text] [Related]
2. Expression of SHP2 and related markers in non-small cell lung cancer: a tissue microarray study of 80 cases.
Tang C; Luo D; Yang H; Wang Q; Zhang R; Liu G; Zhou X
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):386-94. PubMed ID: 23343958
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of SHP2 in the tumor tissues of smokers with lung cancer].
Zhan X; Dong H; Sun C; Liu L; Wang D; Wei Z
Zhongguo Fei Ai Za Zhi; 2010 Sep; 13(9):877-81. PubMed ID: 20840817
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological and prognostic significance of ERα and ERβ expression in lung carcinomas: a tissue microarray study].
Yang X; Xue LY; Liu Y; Guo L; Wen P; Lin DM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):678-83. PubMed ID: 24332055
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CD44s expression in resected non-small cell lung cancer.
Ko YH; Won HS; Jeon EK; Hong SH; Roh SY; Hong YS; Byun JH; Jung CK; Kang JH
BMC Cancer; 2011 Aug; 11():340. PubMed ID: 21819617
[TBL] [Abstract][Full Text] [Related]
6. Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer.
Chen ZL; Zhao SH; Wang Z; Qiu B; Li BZ; Zhou F; Tan XG; He J
Chin J Cancer; 2011 Jan; 30(1):62-8. PubMed ID: 21192845
[TBL] [Abstract][Full Text] [Related]
7. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
[TBL] [Abstract][Full Text] [Related]
8. [Correlations of S100A4 protein expression to invasion and metastasis of non-small cell lung cancer].
Chen XL; Zhang WG; Chen XY; Sun ZM; Liu SH
Ai Zheng; 2006 Sep; 25(9):1134-7. PubMed ID: 16965657
[TBL] [Abstract][Full Text] [Related]
9. SHP2E76K mutant promotes lung tumorigenesis in transgenic mice.
Schneeberger VE; Luetteke N; Ren Y; Berns H; Chen L; Foroutan P; Martinez GV; Haura EB; Chen J; Coppola D; Wu J
Carcinogenesis; 2014 Aug; 35(8):1717-25. PubMed ID: 24480804
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of membrane skeleton protein 4.1 family in non-small cell lung cancer].
Zheng XY; Qi YM; Gao YF; Wang XY; Qi MX; Shi XF; An XL
Ai Zheng; 2009 Jul; 28(7):679-84. PubMed ID: 19624891
[TBL] [Abstract][Full Text] [Related]
11. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of a disintegrin and metalloprotease 8 (ADAM8) and epidermal growth factor receptor (EGFR) in non-small cell lung cancer].
Wu GC; Hu HC; Shi MH
Ai Zheng; 2008 Aug; 27(8):874-8. PubMed ID: 18710625
[TBL] [Abstract][Full Text] [Related]
13. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of Elf-1 and vascular endothelial growth factor in non-small cell lung cancer].
Yang DX; Han YC; Liu LY; Yu N; Wang X; Shi Y
Ai Zheng; 2009 Jul; 28(7):762-7. PubMed ID: 19624906
[TBL] [Abstract][Full Text] [Related]
15. [Expression of granulocyte colony stimulating factor in patients with non-small cell lung cancer and its clinicopathological significance].
Wei LX; Chang WL; Guo AT; Tai YH; Sun L; Shi HY
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):721-5. PubMed ID: 22336152
[TBL] [Abstract][Full Text] [Related]
16. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
[TBL] [Abstract][Full Text] [Related]
17. [Significance of caveolin-1 expression in primary lung cancer].
Yu JH; Wei Q; Qi FJ; Xu HT; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):664-8. PubMed ID: 17374210
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 protein expression correlates with nodal status in non small cell lung cancer.
Groeger AM; Caputi M; Esposito V; De Luca A; Salat A; Murabito M; Giordano GG; Baldi F; Giordano A; Wolner E
Anticancer Res; 1999; 19(1B):821-4. PubMed ID: 10216499
[TBL] [Abstract][Full Text] [Related]
19. [Expression of EYA2 in non-small cell lang cancer].
Guo JT; Ding LH; Liang CY; Zhou NK; Ye QN
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):528-31. PubMed ID: 19950702
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer.
Otsuka S; Klimowicz AC; Kopciuk K; Petrillo SK; Konno M; Hao D; Muzik H; Stolte E; Boland W; Morris D; Magliocco AM; Bebb DG
J Thorac Oncol; 2011 Jul; 6(7):1169-78. PubMed ID: 21623238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]